Recent News
Providence, RI--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today publication of data providing evidence that its novel product candidate addressing scarring and wound healing showed efficacy in a Mycobacterium tuberculosis (TB) animal model.
Based...
Providence, RI--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today that it has initiated a Phase 1/2a clinical evaluation of its novel therapeutic agent, UISH001, for treating urinary incontinence (UI). This FDA-approved study is a 60 patient, placebo...
Providence, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today the simultaneous closing of its over-subscribed Series B offering and its receipt of a U.S. government grant. The former funds, raised exclusively from private investors, are to be...
Copyright Beech Tree Labs, Inc.